Abstract
We reported previously that infection of C3H/HeOuJ (HeOu) mice with the murine intestinal pathogen Citrobacter rodentium caused a selective modulation of hepatic cytochrome P450 (P450) gene expression in the liver that was independent of the Toll-like receptor 4. However, HeOu mice are much more sensitive to the pathogenic effects of C. rodentium infection, and the P450 down-regulation was associated with significant morbidity in the animals. Here, we report that oral infection of C57BL/6 mice with C. rodentium, which produced only mild clinical signs and symptoms, produced very similar effects on hepatic P450 expression in this strain. As in HeOu mice, CYP4A mRNAs and proteins were among the most sensitive to down-regulation, whereas CYP4F18 was induced. CYP2D9 mRNA was also induced 8- to 9-fold in the C57BL/6 mice. The time course of P450 regulation followed that of colonic inflammation and bacterial colonization, peaking at 7 to 10 days after infection and returning to normal at 15 to 24 days as the infection resolved. These changes also correlated with the time course of significant elevations in the serum of the proinflammatory cytokines interleukin (IL)-6 and tumor necrosis factor-α, as well as of interferon-γ and IL-2, with serum levels of IL-6 being markedly higher than those of the other cytokines. Intraperitoneal administration of C. rodentium produced a rapid down-regulation of P450 enzymes that was quantitatively and qualitatively different from that of oral infection, although CYP2D9 was induced in both models, suggesting that the effects of oral infection on the liver are not due to bacterial translocation.
Footnotes
-
This was supported by the National Institutes of Health [Grants GM46897, DK072372, NS44174, AR002157, AI056067-01].
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.108.024240.
-
ABBREVIATIONS: P450, cytochrome P450; LPS, lipopolysaccharide; TLR4, toll-like receptor 4; EPEC, enteropathogenic Escherichia coli; HeOu, C3H/HeOuJ; HeJ, C3H/HeJ; CFU, colony-forming unit; RT, reverse transcriptase; PCR, polymerase chain reaction; IL, interleukin; TNF-α, tumor necrosis factor-α; IFN-γ, interferon-γ; MIP-1α, macrophage inflammatory protein 1α; MCP-1, monocyte chemotactic protein-1; KC, chemokine CXCL1; RANTES, chemokine CCL5; ANOVA, analysis of variance; p.i., postinfection.
-
↵
The online version of this article (available at http://dmd.aspetjournals.org) contains supplemental material.
- Received August 28, 2008.
- Accepted October 23, 2008.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|